Nicotine stimulates expression of proteins implicated in peripheral and central sensitization

Neuroscience

Volumn 290, Issue , 2015, Pages 115-125

  Hawkins, J L ^a   Denson, J E ^a   Miley, D R ^a   Durham, P L ^a  

^a MISSOURI STATE UNIVERSITY   (United States)

Author keywords

Central sensitization; Cytokines; Nicotine; Spinal trigeminal nucleus; Trigeminal ganglion

Indexed keywords

CALCIUM BINDING PROTEIN; CILIARY NEUROTROPHIC FACTOR; CXCL9 CHEMOKINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLIAL FIBRILLARY ACIDIC PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; IONIZED CALCIUM BINDING ADAPTER MOLECULE 1; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE TARTRATE; RANTES; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; COTININE; GANGLION STIMULATING AGENT; NICOTINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM SENSITIZATION; CONTROLLED STUDY; MALE; MECHANICAL STIMULATION; MICROGLIA; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD; SPINAL CORD DORSAL HORN; STIMULUS RESPONSE; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION; WITHDRAWAL REFLEX; ANIMAL; BLOOD; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; PROTEIN MICROARRAY; SPRAGUE DAWLEY RAT; STIMULATION;

ANIMALS; CENTRAL NERVOUS SYSTEM SENSITIZATION; COTININE; CYTOKINES; GANGLIONIC STIMULANTS; IMMUNOHISTOCHEMISTRY; MALE; NICOTINE; NOCICEPTION; PHYSICAL STIMULATION; PROTEIN ARRAY ANALYSIS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TRIGEMINAL GANGLION; TRIGEMINAL NUCLEUS, SPINAL;

EID: 84922379457     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.01.034     Document Type: Article

References (55)

1. Aley K.O., Levine J.D. Role of protein kinase A in the maintenance of inflammatory pain. J Neurosci 1999, 19:2181-2186.
2. Alter B.J., Zhao C., Karim F., Landreth G.E., Gereau R.W. Genetic targeting of ERK1 suggests a predominant role for ERK2 in murine pain models. J Neurosci 2010, 30:11537-11547.
3. Anderson L.E., Seybold V.S. Calcitonin gene-related peptide regulates gene transcription in primary afferent neurons. J Neurochem 2004, 91:1417-1429.
4. Buse D.C., Loder E.W., Gorman J.A., Stewart W.F., Reed M.L., Fanning K.M., Serrano D., Lipton R.B. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache 2013, 53:1278-1299.
5. Cady R.J., Denson J.E., Durham P.L. Inclusion of cocoa as a dietary supplement represses expression of inflammatory proteins in spinal trigeminal nucleus in response to chronic trigeminal nerve stimulation. Mol Nutr Food Res 2013, 57:996-1006.
6. Cady R.J., Denson J.E., Sullivan L.Q., Durham P.L. Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization. Neuroscience 2014, 269:79-92.
7. Cady R.J., Hirst J.J., Durham P.L. Dietary grape seed polyphenols repress neuron and glia activation in trigeminal ganglion and trigeminal nucleus caudalis. Mol Pain 2010, 6:91.
8. Cheng J.K., Ji R.R. Intracellular signaling in primary sensory neurons and persistent pain. Neurochem Res 2008, 33:1970-1978.
9. Cippitelli A., Astarita G., Duranti A., Caprioli G., Ubaldi M., Stopponi S., Kallupi M., Sagratini G., Rodriguez de Fonseca F., Piomelli D., Ciccocioppo R. Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition. PLoS One 2011, 6:e28142.
10. De Simone R., Ajmone-Cat M.A., Carnevale D., Minghetti L. Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation 2005, 2:4.
11. Delbono O., Gopalakrishnan M., Renganathan M., Monteggia L.M., Messi M.L., Sullivan J.P. Activation of the recombinant human alpha 7 nicotinic acetylcholine receptor significantly raises intracellular free calcium. J Pharmacol Exp Ther 1997, 280:428-438.
12. Dodick D., Silberstein S. Central sensitization theory of migraine: clinical implications. Headache 2006, 46(Suppl. 4):S182-S191.
13. Doya H., Ohtori S., Fujitani M., Saito T., Hata K., Ino H., Takahashi K., Moriya H., Yamashita T. C-Jun N-terminal kinase activation in dorsal root ganglion contributes to pain hypersensitivity. Biochem Biophys Res Commun 2005, 335:132-138.
14. Gahring L.C., Persiyanov K., Rogers S.W. Neuronal and astrocyte expression of nicotinic receptor subunit beta4 in the adult mouse brain. J Comp Neurol 2004, 468:322-333.
15. Garrett F.G., Hawkins J.L., Overmyer A.E., Hayden J.B., Durham P.L. Validation of a novel rat-holding device for studying heat- and mechanical-evoked trigeminal nocifensive behavioral responses. J Orofac Pain 2012, 26:337-344.
16. Gosselin R.D., Suter M.R., Ji R.R., Decosterd I. Glial cells and chronic pain. Neuroscientist 2010, 16:519-531.
17. Hoffmann D., Hoffmann I. Chemistry and toxicology. Smoking and tobacco control monograph no 9 2012, National Cancer Institute.
18. Hucho T., Levine J.D. Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007, 55:365-376.
19. Hukkanen J., Jacob P., Benowitz N.L. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005, 57:79-115.
20. Ji R.R. Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Curr Drug Targets Inflamm Allergy 2004, 3:299-303.
21. Ji R.R., Gereau R.W., Malcangio M., Strichartz G.R. MAP kinase and pain. Brain Res Rev 2009, 60:135-148.
22. Josiah D.T., Vincler M.A. Impact of chronic nicotine on the development and maintenance of neuropathic hypersensitivity in the rat. Psychopharmacology 2006, 188:152-161.
23. Kaminska B., Gozdz A., Zawadzka M., Ellert-Miklaszewska A., Lipko M. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat Rec 2009, 292:1902-1913.
24. Kant S., Swat W., Zhang S., Zhang Z.Y., Neel B.G., Flavell R.A., Davis R.J. TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. Genes Dev 2011, 25:2069-2078.
25. Kawasaki Y., Kohno T., Zhuang Z.Y., Brenner G.J., Wang H., Van Der Meer C., Befort K., Woolf C.J., Ji R.R. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 2004, 24:8310-8321.
26. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008, 28:5189-5194.
27. Kohno T., Wang H., Amaya F., Brenner G.J., Cheng J.K., Ji R.R., Woolf C.J. Bradykinin enhances AMPA and NMDA receptor activity in spinal cord dorsal horn neurons by activating multiple kinases to produce pain hypersensitivity. J Neurosci 2008, 28:4533-4540.
28. Latremoliere A., Woolf C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10:895-926.
29. Le H., Tfelt-Hansen P., Skytthe A., Kyvik K.O., Olesen J. Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study. J Headache Pain 2011, 12:157-172.
30. Lee E.Y., Lee Z.H., Song Y.W. CXCL10 and autoimmune diseases. Autoimmun Rev 2009, 8:379-383.
31. Leung L., Cahill C.M. TNF-alpha and neuropathic pain-a review. J Neuroinflammation 2010, 7:27.
32. Liu L., Chang G.Q., Jiao Y.Q., Simon S.A. Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia. Brain Res 1998, 809:238-245.
33. Liu L., Simon S.A. Capsaicin and nicotine both activate a subset of rat trigeminal ganglion neurons. Am J Physiol 1996, 270:C1807-C1814.
34. Lockman P.R., McAfee G., Geldenhuys W.J., Van der Schyf C.J., Abbruscato T.J., Allen D.D. Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure. J Pharmacol Exp Ther 2005, 314:636-642.
35. Malmberg A.B., Brandon E.P., Idzerda R.L., Liu H., McKnight G.S., Basbaum A.I. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. J Neurosci 1997, 17:7462-7470.
36. Michel K., Michaelis M., Mazzuoli G., Mueller K., Vanden Berghe P., Schemann M. Fast calcium and voltage-sensitive dye imaging in enteric neurones reveal calcium peaks associated with single action potential discharge. J Physiol 2011, 589:5941-5947.
37. Miller R.J., Jung H., Bhangoo S.K., White F.A. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 2009, 194:417-449. 10.1007/978-3-540-79090-7_12.
38. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., Tracey K., Martin D., Maier S.F., Watkins L.R. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 2003, 23:1026-1040.
39. Nakamura R., Nishimura T., Ochiai T., Nakada S., Nagatani M., Ogasawara H. Availability of a microglia and macrophage marker, iba-1, for differential diagnosis of spontaneous malignant reticuloses from astrocytomas in rats. J Toxicol Pathol 2013, 26:55-60.
40. Oikawa H., Nakamichi N., Kambe Y., Ogura M., Yoneda Y. An increase in intracellular free calcium ions by nicotinic acetylcholine receptors in a single cultured rat cortical astrocyte. J Neurosci Res 2005, 79:535-544.
41. Pentel P.R., Dufek M.B., Roiko S.A., Lesage M.G., Keyler D.E. Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats. J Pharmacol Exp Ther 2006, 317:660-666.
42. Pietrobon D., Moskowitz M.A. Pathophysiology of migraine. Annu Rev Physiol 2013, 75:365-391.
43. Ren K., Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res Rev 2009, 60:57-64.
44. Rozen T., Swidan S.Z. Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 2007, 47:1050-1055.
45. Rozen T.D. A history of cigarette smoking is associated with the development of cranial autonomic symptoms with migraine headaches. Headache 2011, 51:85-91.
46. Schramm S.H., Obermann M., Katsarava Z., Diener H.C., Moebus S., Yoon M.S. Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. J Headache Pain 2013, 14:40.
47. Seybold V.S. The role of peptides in central sensitization. Handb Exp Pharmacol 2009, 194:451-491.
48. Shi Y., Weingarten T.N., Mantilla C.B., Hooten W.M., Warner D.O. Smoking and pain: pathophysiology and clinical implications. Anesthesiology 2010, 113:977-992.
49. Sun R., Tu Y., Lawand N., Yan J., Lin Q., Willis W. Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization. J Neurophysiol 2004, 92:2859-2866.
50. Tsuda M., Mizokoshi A., Shigemoto-Mogami Y., Koizumi S., Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004, 45:89-95.
51. Uceyler N., Schafers M., Sommer C. Mode of action of cytokines on nociceptive neurons. Exp Brain Res 2009, 196:67-78.
52. Uzar E., Evliyaoglu O., Yucel Y., Ugur Cevik M., Acar A., Guzel I., Islamoglu Y., Colpan L., Tasdemir N. Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur Rev Med Pharmacol Sci 2011, 15:1111-1116.
53. Vause C.V., Durham P.L. Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen. Headache 2012, 52:80-89.
54. Weingarten T.N., Moeschler S.M., Ptaszynski A.E., Hooten W.M., Beebe T.J., Warner D.O. An assessment of the association between smoking status, pain intensity, and functional interference in patients with chronic pain. Pain Physician 2008, 11:643-653.
55. Zvolensky M.J., McMillan K., Gonzalez A., Asmundson G.J. Chronic pain and cigarette smoking and nicotine dependence among a representative sample of adults. Nicotine Tob Res 2009, 11:1407-1414.